Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Muncie, IN Metro Edition
Focus: LIFE SCI
Muncie's slack labor market can't touch scarce science talent.
4.2%
Muncie MSA unemployment
vs 3.3% Indiana, 4.1% national (July 2026)
$95,900
CRA advertised pay, Muncie metro
vs $90,956 national median
-31% YoY
Indiana life sciences job postings
through August 2026, vs active hiring at 64% of biopharma orgs
$177,000
Indiana life sciences avg. wage
vs $223,354 for drug/biological manufacturing roles
This Month's Takeaways
Muncie's labor slack doesn't extend to credentialed science talent.
Metro unemployment sits at 4.2%, nearly a point above the state's 3.3%, but that slack concentrates in lower-skill occupations. Clinical research associates command a $95,900 median locally, above the $90,956 national figure, signaling that credential-driven roles price off a statewide, not metro, labor pool.
Lebanon and Fishers investment is pulling wage gravity north.
Eli Lilly's $13B Medicine Foundry and INCOG BioPharma's expansion to roughly 1,000 workers by 2030 are setting the going rate for CMC, quality, and manufacturing talent within commuting distance of Muncie. Employers anchored in Delaware County should expect retention pressure on any role with a direct analog in those builds.
Outsourcing math tightens as internal scientific hires get costlier.
National data shows regulatory and CMC director-level roles reaching $320K-$580K and $220K-$520K respectively amid acute talent scarcity, a dynamic that makes Muncie-based organizations without Indianapolis-scale budgets more likely to lean on CROs and CDMOs for specialized execution. Local hiring managers competing for these skill sets without matching comp bands risk losing finalists to the Indianapolis corridor.
Flat manufacturing employment masks a credential mismatch, not a demand gap.
Muncie goods-producing employment barely moved in 2025 even as statewide life sciences job postings tightened 31% year-over-year, consistent with employers struggling to fill specific technical roles rather than reducing headcount. Workforce planning should separate general manufacturing softness from the much narrower, much tighter market for quality and production technician roles tied to biologics and injectables.
Local Labor Conditions
Muncie MSA unemployment held at 4.2% in July 2026, nearly a full point above Indiana's 3.3% rate, as manufacturing employment stays flat and labor force participation lags the state's 63% average. Life sciences hiring in the metro remains anchored to institutional anchors — IU Health/Ball Memorial and Ball State — rather than the biotech and CDMO buildout concentrated in Indianapolis, Lebanon, and Fishers, leaving Muncie employers more exposed to regional wage competition than to local labor scarcity.
Leadership & Talent Implications
Muncie's elevated unemployment relative to the state suggests a deeper available labor pool for clinical and administrative support roles, but specialized scientific, regulatory, and CMC talent will still pull against the Indianapolis-metro premium being set by Eli Lilly's Lebanon foundry and INCOG BioPharma's Fishers expansion. Build-vs-outsource calculus in Muncie should account for the fact that credentialed talent — CRAs, regulatory specialists, quality personnel — effectively competes in a statewide, not metro, labor market where advertised pay is already running above national medians. Consider benchmarking specialized roles against the Indianapolis-Lebanon-Fishers corridor rather than Muncie-specific wage data, since candidates with in-demand credentials are mobile across that commuting and recruiting radius.
